Relationship between cyclophilin A levels and matrix metalloproteinase 9 activity in cerebrospinal fluid of cognitively normal apolipoprotein E4 carriers and blood-brain barrier breakdown

JAMA Neurology

Volumn 70, Issue 9, 2013, Pages 1198-1200

  Halliday, Matthew R ^a,b   Pomara, Nunzio ^c   Sagare, Abhay P ^b   Mack, Wendy J ^b   Frangione, Blas ^c   Zlokovic, Berislav V ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; CYCLOPHILIN A; GELATINASE B;

ADULT; AGE; AGED; ALLELE; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL DEMENTIA RATING; COGNITION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN EXPERIMENT; MALE; MINI MENTAL STATE EXAMINATION; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL;

EID: 84883796045     PISSN: 21686149     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamaneurol.2013.3841     Document Type: Article

References (9)

1. Verghese PB, Castellano JM, Holtzman DM. Apolipoprotein E in Alzheimer's disease and other neurological disorders. Lancet Neurol. 2011;10(3):241-252.
2. Zlokovic BV. Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease. JAMA Neurol. 2013;70(4):440-444.
3. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci. 2011;12(12):723-738.
4. Zipser BD, Johanson CE, Gonzalez L, et al. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging. 2007;28(7):977-986. (Pubitemid 46635913)
5. Cortes-Canteli M, Zamolodchikov D, Ahn HJ, Strickland S, Norris EH. Fibrinogen and altered hemostasis in Alzheimer's disease. J Alzheimers Dis. 2012;32(3):599-608.
6. Hultman K, Strickland S, Norris EH. The APOE ε4/ε4 genotype potentiates fibrin(ogen) deposition in amyloid-laden vessels in the brains of Alzheimer's disease patients [published online May 8, 2013]. J Cereb Blood Flow Metab. doi:10.1038/jcbfm.2013.76.
7. Bell RD, Winkler EA, Singh I, et al. Apolipoprotein E controls cerebrovascular integrity via cyclophilin A. Nature. 2012;485(7399):512-516.
8. Blennow K, Wallin A, Fredman P, Karlsson I, Gottfries CG, Svennerholm L. Blood-brain barrier disturbance in patients with Alzheimer's disease is related to vascular factors. Acta Neurol Scand. 1990;81(4):323-326. (Pubitemid 20174132)
9. Pomara N, Bruno D, Sarreal AS, et al. Lower CSF amyloid beta peptides and higher F2-isoprostanes in cognitively intact elderly individuals with major depressive disorder. Am J Psychiatry. 2012;169(5):523-530.